Transaction #17224 · Form 4 · 0001193125-25-313184
Sarepta Therapeutics, Inc. · Stock award · Common Stock
Sarepta Therapeutics, Inc. · Transacted December 7, 2025 · Filed December 9, 2025
What does this filing report?
An SEC Form 4 filing for Sarepta Therapeutics, Inc. records a stock award involving Common Stock on December 7, 2025. The reported quantity was 50,000. The filing date is December 9, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Sarepta Therapeutics, Inc.
- Company CIK
- 0000873303
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 50,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 490,307
- Ownership description
- Not reported
- SEC acceptance time
- Dec 9, 2025, 8:30 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- INGRAM DOUGLAS S ↗
Chief Executive Officer · Director
CIK 0001190644
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The Reporting Person was granted performance-contingent restricted stock units ("Performance-Contingent RSUs"), as described in the Company's 2018 Equity Incentive Plan. Each Performance-Contingent RSU represents the right to receive one share of common stock. The Performance-Contingent RSUs are subject to service- and performance-based vesting criteria.
- F2
- The Reporting Person was granted restricted shares, as described in the Company's 2018 Equity Incentive Plan. The restricted shares are subject to service- and performance-based vesting criteria.
- F3
- The Reporting Person was granted Performance Units, as described in the Company's 2018 Equity Incentive Plan. The Performance Units are subject to service- and performance-based vesting criteria.
- F4
- The Reporting Person was granted Performance Shares, as described in the Company's 2018 Equity Incentive Plan. The Performance Shares are subject to service- and performance-based vesting criteria.
- F5
- The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs are subject to service- and performance-based vesting criteria.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.